Febuxostat 59651-0114
Product NDC
59651-0114- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 25, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA210741
Need to source Febuxostat? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Febuxostat | 80 mg/1 |
Drug Class
Xanthine Oxidase Inhibitor [EPC]Xanthine Oxidase Inhibitor [EPC]Xanthine Oxidase Inhibitors [MoA]
Packaging Options(4)
100 TABLET in 1 BOTTLE (59651-114-01)
500 TABLET in 1 BOTTLE (59651-114-05)
30 TABLET in 1 BOTTLE (59651-114-30)
90 TABLET in 1 BOTTLE (59651-114-90)